Published Nov 9, 2026, 8:21 PM ET · Updated 4 days ago · 1 source
P3 Health Partners raises 2026 adjusted EBITDA guidance range to $90M-$110M as it targets $200M in value creation
Seeking Alpha
·
Original Report
P3 Health Partners raises 2026 adjusted EBITDA guidance range to $90M-$110M as it targets $200M in value creation